Page 2 - Develop Drugs News Today

Alvotech (ALVO) said it began a confirmatory patient study for AVT03, a biosimilar of Amgen's (AMGN) bone disorder drugs Prolia and Xgeva.The Iceland-based company said the aim of...

Hutchmed (China) (HCM) said its medicine fruquintinib met the main goal of overall survival ((OS)) in patients with advanced, refractory metastatic colorectal cancer ((CRC)) in a phase...

Genelux Corp. is seeking U.S. public capital market investment to fund further advancement of its pipeline. Click here to read more about GNLX's $30m IPO filing.

14 new highs and up 68.36% in the last month. Price target of $38.00 to as high as $51.00. Trading about its 20, 50 and 100-day moving averages.

AZoRobotics speaks to researchers from the University of Oslo about creating an artificial intelligence (AI)-based virtual screening algorithm and a cross-species Alzheimer’s disease (AD) drug verification system.

Plus, What fundraisers are doing as the pandemic eases, and the Moore Foundation commits $300 million more to Amazon conservation

Longeveron obtained Rare Pediatric Designation of Lomecel-B for patients with HLHS. Here's why LGVN stock is worth a look as a speculative buy.

Jeanne Kehren war bei Sanofi und Novartis erfolgreich. Bei Bayer setzt die Französin auf digitale Therapien und Kooperationen mit Start-ups.